ArticleAmerican journal of hematology2013

Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors.

Lorenzo Falchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.